4 May 2020
Sidley Represents Hengrui Medicine in its License Agreement with CrystalGenomics
Advising firms
Deal team
2 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Thomas Duley Lead | Sidley | Partner | Technology and IP Transactions | San Francisco |
| Ruchun Ji Lead | Sidley | Partner | M&A/Private Equity | Shanghai |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 87.8m (US$87.75 million)
- What the figure measures
- Total transaction value
- Client
- Jiangsu Hengrui Medicine Co., Ltd.Sell-side
- Counterparties
- CrystalGenomics, Inc. (Buy-side)